電気薬学/生体電気薬の世界市場：心臓ペースメーカー、人工内耳、脊髄刺激器、植込み型除細動器、脳深部刺激器...市場調査レポートについてご紹介

1 Introduction (Page No. – 20)
1.1 Objectives of Study
1.2 Electroceuticals Market Definition
1.3 Electroceuticals Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 23)
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Key Industry Insights
2.3 Key Data From Primary Sources
2.4 Key Insights From Primary Sources
2.5 Electroceuticals Market Size Estimation Methodology
2.6 Research Design
2.7 Electroceuticals Market Data Validation and Triangulation
2.8 Assumptions for the Study

3 Executive Summary (Page No. – 35)
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook

4 Premium Insights (Page No. – 40)
4.1 Global Electroceuticals Market
4.2 Global Electroceuticals Market, By Product
4.3 Global Electroceuticals Market, By Region and Deep Brain Stimulation Applications
4.4 Global Electroceuticals Market, By Region
4.5 Global Electroceuticals Market, By End User (2016 vs. 2021)

5 Market Overview (Page No. – 45)
5.1 Introduction
5.2 Electroceuticals Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Geriatric Population
5.2.1.2 Regulatory Approval for New and Advanced Electroceuticals
5.2.1.3 Growing Investments and Funds for the Development of Novel Therapies and Electroceuticals
5.2.1.4 Rising Prevalence of Neurological Disorders
5.2.1.5 Growing Prevalence of Hearing Loss
5.2.2 Restraints
5.2.2.1 Lack of Skilled Professionals
5.2.2.2 High Cost of Cochlear Implants
5.2.3 Opportunities
5.2.3.1 Growth Potential Offered By Emerging Countries
5.2.3.2 Strong Product Pipeline
5.2.4 Challenges
5.2.4.1 Unfavorable Reimbursement Scenario

6 Global Electroceuticals Market, By Product (Page No. – 54)
6.1 Introduction
6.2 Implantable Cardioverter Defibrillators
6.3 Cardiac Pacemakers
6.4 Spinal Cord Stimulators
6.5 Cochlear Implants
6.6 Deep Brain Stimulators
6.7 Transcutaneous Electrical Nerve Stimulators
6.8 Vagus Nerve Stimulators
6.9 Sacral Nerve Stimulators
6.10 Retinal Implants
6.11 Other Electrical Stimulators

7 Global Electroceuticals Market, By Type of Device (Page No. – 74)
7.1 Introduction
7.2 Implantable Electroceutical Devices
7.3 Non-Invasive Electroceutical Devices

8 Global Electroceuticals Market, By Application (Page No. – 80)
8.1 Introduction
8.2 Cardiac Pacemakers and Implantable Cardioverter Defibrillators Market, By Application
8.2.1 Arrhythmia
8.3 Spinal Cord Stimulators (SCS) Market, By Application
8.3.1 Chronic Pain
8.3.2 Failed Back Syndrome (FBSS)
8.3.3 Ischemia
8.4 Cochlear Implants Market, By Application
8.4.1 Sensorineural Hearing Loss
8.5 Deep Brain Stimulators (DBS) Market, By Application
8.5.1 Parkinson’s Disease
8.5.2 Tremor
8.5.3 Depression
8.5.4 Other Deep Brain Stimulation Applications
8.6 Transcutaneous Electrical Nerve Stimulators (RENS) Market, By Application
8.6.1 Treatment-Resistant Depression
8.6.2 Other Transcutaneous Electrical Stimulation Applications
8.7 Vagus Nerve Stimulators Market (VNS), By Application
8.7.1 Epilepsy
8.7.2 Other Vagus Nerve Stimulation Applications
8.8 Sacral Nerve Stimulators (SNS) Market, By Application
8.8.1 Urinary Incontinence
8.8.2 Fecal Incontinence
8.9 Retinal Implants Market, By Application
8.9.1 Retinitis Pigmentosa
8.10 Other Electrical Stimulators Market, By Application
8.10.1 Gastroparesis
8.10.2 Obesity
8.10.3 Depression
8.10.4 Migraine
8.10.5 Spinal Cord Injury

9 Global Electroceuticals Market, By End User (Page No. – 115)
9.1 Introduction
9.2 Hospitals
9.3 Research Institutes
9.4 Individual Users

10 Global Electroceuticals Market, By Region (Page No. – 123)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.1.1 Rising Prevalence of Arrhythmia in the U.S.
10.2.1.2 Rising Prevalence of Chronic Diseases in the U.S.
10.2.1.3 High Prevalence of Hearing Loss in the U.S.
10.2.1.4 Rising Incidence of Rp Driving the Demand for Retinal Implants
10.2.1.5 Conferences & Annual Meetings
10.2.1.6 Increasing Regulatory Approvals in the U.S.
10.2.2 Canada
10.2.2.1 Growing Burden of Cancer and Diabetes in Canada
10.2.2.2 Increase in Hearing Loss, Owing to Rising Aging Population
10.3 Europe
10.3.1 Rapidly Aging Population in Europe
10.3.2 Conferences & Annual Meetings
10.3.3 Government Support for Hearing Implants
10.3.4 Rising Prevalence of Neurological Diseases in Germany and France
10.3.5 Rising Prevalence of Diabetes in the U.K. and Rest of Europe
10.3.6 Increasing Regulatory Approvals in Europe
10.4 Asia-Pacific
10.4.1 Rising Aging Population Driving Increase in Disease Incidence in Japan
10.4.2 Increasing Prevalence of Diabetes and Rapidly Aging Population in China
10.4.3 Increasing Prevalence of Hearing Loss in Asia-Pacific Region
10.4.4 Increasing Geriatric Population & High Diabetes Prevalence in India
10.4.5 Conferences on Electroceutical Devices in Apac
10.4.6 Increasing Prevalence of Parkinson’s Disease in Singapore
10.5 Rest of World
10.5.1 Rise in Aging Population & Prevalence of Diabetes in the Middle East and Africa
10.5.2 Conferences on Electroceutical Devices in Latin America and Africa
10.5.3 Growing Cases of Cancer in Latin America

11 Competitive Landscape (Page No. – 163)
11.1 Overview
11.2 Competitive Situation and Trends
11.2.1 Introduction
11.2.2 Product Launches
11.2.3 Approvals
11.2.4 New Product Launches
11.2.5 Agreements, Collaborations, Joint Ventures, and Partnerships
11.2.6 Marketing and Promotion Activities
11.2.7 Acquisitions and Mergers
11.2.8 Expansions
11.2.9 Other Strategies
11.3 Global Electroceuticals Market: Empirical Assessment of Growth Strategies
11.3.1 Route to Strategic Growth: Organic and Inorganic Growth Strategies
11.3.2 Organic Growth Strategies
11.3.3 Inorganic Growth Strategies

12 Company Profiles (Page No. – 175)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, Mnm View)*
12.1 Introduction
12.2 Medtronic PLC
12.3 St. Jude Medical, Inc.
12.4 Boston Scientific Corporation
12.5 Cochlear Limited
12.6 Sonova Holding AG
12.7 Livanova PLC
12.8 Biotronik
12.9 Nevro Corp.
12.10 Second Sight Medical Products, Inc.
12.11 Electrocore LLC

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. – 201)
13.1 Discussion Guide
13.2 Company Developments (2013-2016)
13.2.1 Medtronic PLC
13.2.2 St. Jude Medical, Inc.
13.2.3 Boston Scientific Corporation
13.2.4 Cochlear Limited
13.2.5 Livanova PLC
13.2.6 Biotronik
13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.4 Introducing RT: Real-Time Market Intelligence
13.5 Available Customizations
13.7 Related Reports